The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up : effect on patient-perceived involvement, satisfaction with care, and usefulness. / Kargo, Anette Stolberg; Jensen, Pernille Tine; Lindemann, Kristina; Hjollund, Niels Henrik Ingvar; Lund, Bente; Haee, Mette; Möller, Sören; Hansen, Dorte Gilså; Dahl Steffensen, Karina.

I: Acta Oncologica, Bind 60, Nr. 4, 04.2021, s. 434-443.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Kargo, Anette Stolberg ; Jensen, Pernille Tine ; Lindemann, Kristina ; Hjollund, Niels Henrik Ingvar ; Lund, Bente ; Haee, Mette ; Möller, Sören ; Hansen, Dorte Gilså ; Dahl Steffensen, Karina. / The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up : effect on patient-perceived involvement, satisfaction with care, and usefulness. I: Acta Oncologica. 2021 ; Bind 60, Nr. 4. s. 434-443.

Bibtex

@article{7acf8e47d2c4482681d7b75cb21ace91,
title = "The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness",
abstract = "BACKGROUND: Patients with ovarian cancer often experience substantial health problems and side effects resulting in reduced quality of life (QoL). Different models of using patient-reported outcome measures (PROMs) during follow-up may improve the quality of care. This national, multicenter observational study investigated the effect of active use of PROMs on patient-perceived involvement, satisfaction with care, unmet needs, and QoL during follow-up of ovarian cancer.MATERIAL AND METHODS: Ovarian cancer patients were recruited at the end of primary treatment at eight centers in Denmark. During 18 months of follow-up patients repeatedly completed European Organization for Research and Treatment of Cancer (EORTC) questionnaires covering health related QoL and symptoms. At the sites using PROMs actively (ACT), the clinician had access to an overview of the patient's scores during the clinical encounter. Clinicians using PROMs passively were alerted in case of severe development of symptoms. Following each encounter, patients evaluated their health service experience by completing the CollaboRATE scale of involvement in decision making, the Patient Experience Questionnaire, and ad hoc questions covering patient-perceived usefulness of the PROMs.RESULTS: A total of 223 patients were enrolled, i.e., 168 (75.3%) at five sites using ACT and 53 (23.8%) at three sites using them passively. We found no statistically significant difference in involvement in the decision making, satisfaction with care, unmet needs, and QoL between the two groups. The majority of patients found it useful to complete the PROMs, although it did not seem to significantly support them in raising issues with the oncologist.CONCLUSION: Active use of PROMs did not improve patients' experience of involvement in follow-up care as compared to passive use.",
author = "Kargo, {Anette Stolberg} and Jensen, {Pernille Tine} and Kristina Lindemann and Hjollund, {Niels Henrik Ingvar} and Bente Lund and Mette Haee and S{\"o}ren M{\"o}ller and Hansen, {Dorte Gils{\aa}} and {Dahl Steffensen}, Karina",
year = "2021",
month = apr,
doi = "10.1080/0284186X.2021.1891281",
language = "English",
volume = "60",
pages = "434--443",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Taylor & Francis ",
number = "4",

}

RIS

TY - JOUR

T1 - The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up

T2 - effect on patient-perceived involvement, satisfaction with care, and usefulness

AU - Kargo, Anette Stolberg

AU - Jensen, Pernille Tine

AU - Lindemann, Kristina

AU - Hjollund, Niels Henrik Ingvar

AU - Lund, Bente

AU - Haee, Mette

AU - Möller, Sören

AU - Hansen, Dorte Gilså

AU - Dahl Steffensen, Karina

PY - 2021/4

Y1 - 2021/4

N2 - BACKGROUND: Patients with ovarian cancer often experience substantial health problems and side effects resulting in reduced quality of life (QoL). Different models of using patient-reported outcome measures (PROMs) during follow-up may improve the quality of care. This national, multicenter observational study investigated the effect of active use of PROMs on patient-perceived involvement, satisfaction with care, unmet needs, and QoL during follow-up of ovarian cancer.MATERIAL AND METHODS: Ovarian cancer patients were recruited at the end of primary treatment at eight centers in Denmark. During 18 months of follow-up patients repeatedly completed European Organization for Research and Treatment of Cancer (EORTC) questionnaires covering health related QoL and symptoms. At the sites using PROMs actively (ACT), the clinician had access to an overview of the patient's scores during the clinical encounter. Clinicians using PROMs passively were alerted in case of severe development of symptoms. Following each encounter, patients evaluated their health service experience by completing the CollaboRATE scale of involvement in decision making, the Patient Experience Questionnaire, and ad hoc questions covering patient-perceived usefulness of the PROMs.RESULTS: A total of 223 patients were enrolled, i.e., 168 (75.3%) at five sites using ACT and 53 (23.8%) at three sites using them passively. We found no statistically significant difference in involvement in the decision making, satisfaction with care, unmet needs, and QoL between the two groups. The majority of patients found it useful to complete the PROMs, although it did not seem to significantly support them in raising issues with the oncologist.CONCLUSION: Active use of PROMs did not improve patients' experience of involvement in follow-up care as compared to passive use.

AB - BACKGROUND: Patients with ovarian cancer often experience substantial health problems and side effects resulting in reduced quality of life (QoL). Different models of using patient-reported outcome measures (PROMs) during follow-up may improve the quality of care. This national, multicenter observational study investigated the effect of active use of PROMs on patient-perceived involvement, satisfaction with care, unmet needs, and QoL during follow-up of ovarian cancer.MATERIAL AND METHODS: Ovarian cancer patients were recruited at the end of primary treatment at eight centers in Denmark. During 18 months of follow-up patients repeatedly completed European Organization for Research and Treatment of Cancer (EORTC) questionnaires covering health related QoL and symptoms. At the sites using PROMs actively (ACT), the clinician had access to an overview of the patient's scores during the clinical encounter. Clinicians using PROMs passively were alerted in case of severe development of symptoms. Following each encounter, patients evaluated their health service experience by completing the CollaboRATE scale of involvement in decision making, the Patient Experience Questionnaire, and ad hoc questions covering patient-perceived usefulness of the PROMs.RESULTS: A total of 223 patients were enrolled, i.e., 168 (75.3%) at five sites using ACT and 53 (23.8%) at three sites using them passively. We found no statistically significant difference in involvement in the decision making, satisfaction with care, unmet needs, and QoL between the two groups. The majority of patients found it useful to complete the PROMs, although it did not seem to significantly support them in raising issues with the oncologist.CONCLUSION: Active use of PROMs did not improve patients' experience of involvement in follow-up care as compared to passive use.

U2 - 10.1080/0284186X.2021.1891281

DO - 10.1080/0284186X.2021.1891281

M3 - Journal article

C2 - 33651647

VL - 60

SP - 434

EP - 443

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 4

ER -